Freehold Surgical

FreeHold Surgical is a private medical device company developing a novel class of intracorporeal, adjustable retractors for minimally invasive abdominal and pelvic surgeries. Its core innovation lies in devices that are deployed through standard 5mm trocars, provide hands-free and continuously adjustable retraction, and eliminate the need for an assistant or dedicated extra port. The technology targets key limitations in laparoscopic and robotic surgery by improving surgeon autonomy and visualization while potentially reducing incision-related complications compared to existing retraction methods like the Nathanson retractor. The company appears to be in the commercial stage with FDA-registered products, targeting early revenue generation.

Proprietary, fully adjustable, intracorporeal retractor systems (FreeHold Duo and Trio) for hands-free tissue retraction in laparoscopic and robotic surgery. The platform enables deployment through standard 5mm trocars, continuous intraoperative adjustment, and aims to eliminate the need for extra ports or surgical assistants.

Competitors include traditional mechanical retractors (e.g., Nathanson liver retractor), suture-based suspension techniques, and other laparoscopic graspers/retractors held by an assistant. FreeHold's differentiation lies in its hands-free, adjustable, and intracorporeal design, positioning it as a potential disruptor in a segment dominated by simpler, often problematic tools.